0001958173-24-000001.txt : 20240925 0001958173-24-000001.hdr.sgml : 20240925 20240924185532 ACCESSION NUMBER: 0001958173-24-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20240925 DATE AS OF CHANGE: 20240924 EFFECTIVENESS DATE: 20240925 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Orion Therapeutics, Inc. CENTRAL INDEX KEY: 0001958173 ORGANIZATION NAME: IRS NUMBER: 882189627 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-524886 FILM NUMBER: 241321052 BUSINESS ADDRESS: STREET 1: 2641 OSPREY VISTA WAY STREET 2: LAB 150A CITY: KNOXVILLE STATE: TN ZIP: 37920 BUSINESS PHONE: 865-771-7024 MAIL ADDRESS: STREET 1: 2641 OSPREY VISTA WAY STREET 2: LAB 150A CITY: KNOXVILLE STATE: TN ZIP: 37920 D 1 primary_doc.xml X0708 D LIVE 0001958173 Orion Therapeutics, Inc. 2641 OSPREY VISTA WAY LAB 150A KNOXVILLE TN TENNESSEE 37920 865-771-7024 DELAWARE None None Corporation true 2022 Richard Kern Fisher 2641 Osprey Vista Way Lab 150A Knoxville TN TENNESSEE 37920 Executive Officer Director Michael McCaman 2641 Osprey Vista Way Lab 150A Knoxville TN TENNESSEE 37920 Executive Officer Director Deidra Mountain 2641 Osprey Vista Way Lab 150A Knoxville TN TENNESSEE 37920 Director Biotechnology $1 - $1,000,000 06b false 2024-09-10 false true false 0 250000 85000 165000 true 0 4 0 0 45000 true false Orion Therapeutics, Inc. /R. Scott Evans/ R. Scott Evans Attorney 2024-09-24